Vimarsana
Biggest News Aggregation in the World

Page 28 - Meeting Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Meeting Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Meeting Program Today - Breaking & Trending Today

FDA Roundup: July 21, 2023 - Vimarsana News

FDA Roundup: July 21, 2023

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA Center for...

Filbo 2023, to the rescue of traditional indigenous knowledge - Vimarsana News

Filbo 2023, to the rescue of traditional indigenous knowledge

It seeks to create a narrative for inclusion and diversity.

Journal of Clinical Oncology Publishes Rapid Communication Featuring Updated Clinical Data for Adagrasib as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors - Vimarsana News

Journal of Clinical Oncology Publishes Rapid Communication Featuring Updated Clinical Data for Adagrasib as a Targeted Treatment for KRASG12C-Mutated Advanced Solid Tumors

/PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, announced today the Journal of Clinical Oncology published...

First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL - Vimarsana News

First Prospective Study of TKI Ponatinib Shows Benefit in Ph+ALL

The study findings add new insights, but also raise new questions, about the best treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.

White Gold Corp. Announces Webinar to Provide Overview of its Fully Funded $6 Million 2022 Exploration Program & Corporate Update - Vimarsana News

White Gold Corp. Announces Webinar to Provide Overview of its Fully Funded $6 Million 2022 Exploration Program & Corporate Update

TORONTO, June 02, 2022 -- White Gold Corp. is pleased to announce that the Company will be hosting a Webinar on Tuesday, June 7th, 2022. Join CEO, David D’Onofrio; Co-founder & Chief... | June 2, 2022